Eyebright Medical Technology Beijing Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Eyebright Medical Technology Beijing Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Eyebright Medical Technology Beijing Co Ltd (688050) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥76.92 Million ≈ $11.26 Million USD) by net assets (CN¥3.01 Billion ≈ $440.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Eyebright Medical Technology Beijing Co Ltd (2016–2025)

Cash flow conversion efficiency of Eyebright Medical Technology Beijing Co Ltd from 2016 to 2025. This chart illustrates how Eyebright Medical Technology Beijing Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Eyebright Medical Technology Beijing Co for real-time trading data and today's change.

Eyebright Medical Technology Beijing Co Ltd Cash Flow Conversion Ratio Explained

Eyebright Medical Technology Beijing Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Eyebright Medical Technology Beijing Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eyebright Medical Technology Beijing Co Ltd ranked by their cash flow conversion efficiency. Also see 688050 market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Nhn Entertain
KO:181710
-0.025x
Tibet Urban Development and Investment Co Ltd
SHG:600773
-0.009x
Canfor Corporation
TO:CFP
0.079x
Gansu Guofang Gongmao(Grp)
SHG:601086
0.031x
Everi Holdings Inc
NYSE:EVRI
1.295x
Shenzhen Beauty Star Co Ltd
SHE:002243
0.009x
Nutex Health Inc
NASDAQ:NUTX
0.067x
Wolfspeed, Inc.
NYSE:WOLF
-0.058x

Annual Cash Flow Conversion Efficiency for Eyebright Medical Technology Beijing Co Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Eyebright Medical Technology Beijing Co Ltd from 2016 to 2025. Review 688050 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.97 Billion
≈ $434.64 Million
CN¥369.15 Million
≈ $54.02 Million
0.124x -5.86%
2024-12-31 CN¥2.63 Billion
≈ $385.47 Million
CN¥347.75 Million
≈ $50.89 Million
0.132x +37.45%
2023-12-31 CN¥2.36 Billion
≈ $344.75 Million
CN¥226.27 Million
≈ $33.11 Million
0.096x -26.27%
2022-12-31 CN¥1.92 Billion
≈ $280.98 Million
CN¥250.13 Million
≈ $36.60 Million
0.130x +3.37%
2021-12-31 CN¥1.74 Billion
≈ $254.64 Million
CN¥219.30 Million
≈ $32.09 Million
0.126x +58.11%
2020-12-31 CN¥1.55 Billion
≈ $226.47 Million
CN¥123.35 Million
≈ $18.05 Million
0.080x +2.21%
2019-12-31 CN¥647.52 Million
≈ $94.75 Million
CN¥50.49 Million
≈ $7.39 Million
0.078x +35.73%
2018-12-31 CN¥553.87 Million
≈ $81.05 Million
CN¥31.82 Million
≈ $4.66 Million
0.057x +174.70%
2017-12-31 CN¥198.44 Million
≈ $29.04 Million
CN¥4.15 Million
≈ $607.32K
0.021x +216.46%
2016-12-31 CN¥187.52 Million
≈ $27.44 Million
CN¥-3.37 Million
≈ $-492.75K
-0.018x --

About Eyebright Medical Technology Beijing Co Ltd

SHG:688050 China Medical Instruments & Supplies
Market Cap
$1.24 Billion
CN¥8.45 Billion CNY
Market Cap Rank
#7735 Global
#1684 in China
Share Price
CN¥43.71
Change (1 day)
-1.75%
52-Week Range
CN¥36.26 - CN¥65.12
All Time High
CN¥385.84
About

Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for opht… Read more